Literature DB >> 1838546

Visual outcomes of pituitary adenoma surgery. St. Vincent's Hospital 1968-1987.

L J Sullivan1, J O'Day, P McNeill.   

Abstract

Pituitary tumors are a significant cause of visual morbidity. The medical records of 45 patients with histologically verified pituitary adenoma and visual defects (fields and/or acuity) were reviewed. The patients' ages ranged from 19 to 80 years with a mean of 52.4 years. Ophthalmologists referred 76% of the patients for neurosurgical opinion. Bitemporal field defects were present in 89%. Twenty-three patients underwent transfrontal craniotomy prior to 1984, and the remaining twenty-two subsequently had transsphenoidal microsurgery. Of those eyes with abnormal visual acuity preoperatively, 74% had improvement noted postoperatively (p less than 0.001). Of those eyes with preoperatively abnormal visual fields, 68% improved (p less than 0.001). For transsphenoidal surgery the rate of improvement for fields was 81%. Preoperative visual acuity, visual field score, and patient age, were not predictive of postoperative acuity. Optic disc pallor was associated with poorer postoperative fields and acuity compared to eyes without preoperative pallor. Transsphenoidal surgery is effective treatment for visual compromise due to pituitary adenoma, and the need for early diagnosis is emphasized.

Entities:  

Mesh:

Year:  1991        PMID: 1838546

Source DB:  PubMed          Journal:  J Clin Neuroophthalmol        ISSN: 0272-846X


  9 in total

1.  Detection of Visual Field Loss in Pituitary Disease: Peripheral Kinetic Versus Central Static.

Authors:  Fiona J Rowe; Christopher P Cheyne; Marta García-Fiñana; Carmel P Noonan; Claire Howard; Jayne Smith; Joanne Adeoye
Journal:  Neuroophthalmology       Date:  2015-05-13

2.  Predictive model for recovery of visual field after surgery of pituitary adenoma.

Authors:  Junwon Lee; Seung Woo Kim; Dong Wook Kim; Joo Youn Shin; Moonjung Choi; Min Chul Oh; Seung Min Kim; Eui Hyun Kim; Sun Ho Kim; Suk Ho Byeon
Journal:  J Neurooncol       Date:  2016-07-30       Impact factor: 4.130

3.  Prognostic factors of visual field improvement after trans-sphenoidal approach for pituitary macroadenomas: review of the literature and analysis by quantitative method.

Authors:  Lina Raffaella Barzaghi; Marzia Medone; Marco Losa; Stefania Bianchi; Massimo Giovanelli; Pietro Mortini
Journal:  Neurosurg Rev       Date:  2011-11-15       Impact factor: 3.042

4.  Predictive factors for vision recovery after optic nerve decompression for chronic compressive neuropathy: systematic review and meta-analysis.

Authors:  Andrew P Carlson; Martina Stippler; Orrin Myers
Journal:  J Neurol Surg B Skull Base       Date:  2012-11-26

5.  MRI visualization of complete bilateral optic nerve involvement by pituitary adenoma: a case report.

Authors:  K Arita; T Uozumi; T Yano; M Sumida; Z Muttaqin; H Hibino; M Yonezawa
Journal:  Neuroradiology       Date:  1993       Impact factor: 2.804

6.  Predictors of visual outcome with transsphenoidal excision of pituitary adenomas having suprasellar extension: A prospective series of 100 cases and brief review of the literature.

Authors:  Amit Kumar Thotakura; Mohana Rao Patibandla; Manas K Panigrahi; Gokul Chowdary Addagada
Journal:  Asian J Neurosurg       Date:  2017 Jan-Mar

7.  Machine Learning Prediction of Visual Outcome after Surgical Decompression of Sellar Region Tumors.

Authors:  Nidan Qiao; Yichen Ma; Xiaochen Chen; Zhao Ye; Hongying Ye; Zhaoyun Zhang; Yongfei Wang; Zhaozeng Lu; Zhiliang Wang; Yiqin Xiao; Yao Zhao
Journal:  J Pers Med       Date:  2022-01-25

8.  Predictive value of retinal nerve fibre layer thickness for postoperative visual improvement in patients with pituitary macroadenoma.

Authors:  Deepthi Elizabeth Kurian; Rajshekhar V; Saban Horo; Ari G Chacko; Krishna Prabhu; Gowri Mahasampath; Sanita Korah
Journal:  BMJ Open Ophthalmol       Date:  2022-07

9.  [Optical coherence tomography as a predictor of visual recovery in patients with pituitary macroadenomas].

Authors:  Sofía Beltrame; Jorge Rasmussen; Pedro Plou; Moira Altszul; Claudio Yampolsky; Pablo Ajler
Journal:  Surg Neurol Int       Date:  2018-08-13
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.